Nova-ther Technologies

Westerville, OH 43081

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $712K
First Award Date 09/23/02
Most Recent Award Date 09/30/09

Key Personnel

Last Name Name Awards Contact
Bauer John Anthony Bauer 4

4 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 09/30/09 - 08/31/10

DESCRIPTION (provided by applicant): Despite improvements in worldwide health and advances in medical practice the incidence of preterm birth continues to rise in virtually every region of the globe and is accounts for nearly 15% of all live births in the United States. Associated with this increased population of very low birth-weight infants a...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/10/08 - 09/15/08

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 09/15/07 - 08/31/09

DESCRIPTION (provided by applicant): Despite its widespread use, the clinical utility of doxorubicin (DOX) is specifically compromised by dose-limiting cardiotoxicities. Currently approved therapy (dexrazoxane) has only modest value in adults and its usefulness in children for cardiac protection is still being investigated. Efficacy of DOX also ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/23/02 - 09/22/03

DESCRIPTION (provided by applicant): Doxorubicin (DOX) is an important anticancer drug with a wide array of therapeutic uses. Despite its very frequent clinical use, the utility of DOX is severely compromised by dose-limiting cardiotoxicities. While DOX cardiotoxicity has been known for many years, it remains a contemporary problem and therapie...